JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5001
Pure Cycle
PCYO
$261M
| $41K | ﹤0.01% |
4,172
-197
| -5% | -$1.95K |
2017 Q4
5 quarters
|
|
5002
Tiptree Inc
TIPT
$648M
| $41K | ﹤0.01% |
6,475
-16,140
| -71% | -$96.9K |
2017 Q4
5 quarters
|
|
|
EVBN
5003
DELISTED
Evans Bancorp Inc
EVBN
| $41K | ﹤0.01% |
1,139
-54
| -5% | -$1.89K |
2017 Q4
5 quarters
|
|
|
PETX
5004
DELISTED
Aratana Therapeutics, Inc.
PETX
| $41K | ﹤0.01% |
11,309
-39,116
| -78% | -$170K |
2017 Q3
6 quarters
|
|
|
INSY
5005
DELISTED
Insys Therapeutics, Inc.
INSY
| $41K | ﹤0.01% |
8,978
-77,374
| -90% | -$366K |
2014 Q4
17 quarters
|
|
5006
Fidelity D&D Bancorp
FDBC
$314M
| $40K | ﹤0.01% |
682
-143
| -17% | -$8.59K |
2018 Q2
3 quarters
|
|
5007
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.82B
| $40K | ﹤0.01% |
+789
| New | +$39.6K |
2019 Q1
0 quarters
|
|
5008
iShares International Treasury Bond ETF
IGOV
$1.3B
| $40K | ﹤0.01% |
818
| – | – |
2018 Q2
3 quarters
|
|
5009
Rocky Brands
RCKY
$344M
| $40K | ﹤0.01% |
1,667
-78
| -4% | -$2.12K |
2016 Q2
11 quarters
|
|
5010
Universal Logistics Holdings
ULH
$467M
| $40K | ﹤0.01% |
2,028
-40,330
| -95% | -$838K |
2013 Q2
23 quarters
|
|
|
SBOW
5011
DELISTED
SilverBow Resources, Inc.
SBOW
| $40K | ﹤0.01% |
1,729
-82
| -5% | -$1.91K |
2018 Q3
2 quarters
|
|
|
CLUB
5012
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $40K | ﹤0.01% |
8,450
+4,750
| +128% | +$27.1K |
2017 Q2
7 quarters
|
|
5013
LiveOne
LVO
$36.2M
| $39K | ﹤0.01% |
719
-33
| -4% | -$1.96K |
2018 Q2
3 quarters
|
|
5014
PUT
MidCap Financial Investment
MFIC
$705M
| $39K | ﹤0.01% |
+2,600
| New | +$39K |
2019 Q1
0 quarters
|
|
|
NAGE
5015
Niagen Bioscience
NAGE
$218M
| $39K | ﹤0.01% |
9,389
-441
| -4% | -$1.59K |
2018 Q2
3 quarters
|
|
|
SVVC
5016
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
| $39K | ﹤0.01% |
2,966
+2,939
| +10,885% | +$39.2K |
2018 Q4
1 quarter
|
|
|
ADMS
5017
DELISTED
Adamas Pharmaceuticals
ADMS
| $39K | ﹤0.01% |
5,429
-255
| -4% | -$2.29K |
2014 Q2
19 quarters
|
|
|
RWLS
5018
DELISTED
Direxion Russell Large Over Small Cap ETF
RWLS
| $39K | ﹤0.01% |
+700
| New | +$37K |
2019 Q1
0 quarters
|
|
|
ENFC
5019
DELISTED
Entegra Financial Corp.
ENFC
| $39K | ﹤0.01% |
1,708
-1,277
| -43% | -$29.6K |
2017 Q4
5 quarters
|
|
|
CLSD
5020
DELISTED
Clearside Biomedical
CLSD
| $38K | ﹤0.01% |
1,809
-2,944
| -62% | -$58.4K |
2017 Q4
5 quarters
|
|
5021
Harvard Bioscience
HBIO
$38.8M
| $38K | ﹤0.01% |
888
-42
| -5% | -$1.52K |
2018 Q1
4 quarters
|
|
5022
LCNB Corp
LCNB
$269M
| $38K | ﹤0.01% |
2,194
-6,075
| -73% | -$101K |
2017 Q4
5 quarters
|
|
5023
NI Holdings
NODK
$322M
| $38K | ﹤0.01% |
2,369
-112
| -5% | -$1.73K |
2017 Q4
5 quarters
|
|
|
STRS
5024
DELISTED
STRATUS PPTYS INC
STRS
| $38K | ﹤0.01% |
1,442
-186
| -11% | -$4.59K |
2016 Q4
9 quarters
|
|
|
PBIP
5025
DELISTED
Prudential Bancorp, Inc.
PBIP
| $38K | ﹤0.01% |
2,166
-579
| -21% | -$10.4K |
2017 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.